Published on 10 May 2024
Preserve the US interchangeable standard that has helped drive physician and patient confidence in biosimilars
Author(s): Michael S Reilly, Esq
formulary, interchangeable biosimilar, market uptake, pharmacy benefit managers
DOI: 10.5639/gabij.2024.1301.006
2.310 views